Upregulation and clustering of integrins result in increased outside‐in signaling by activating FAK, Src, PI3K‐Akt, and MAPK followed by increased cancer cell migration, protease activation, ECM stiffness, anchorage‐independent survival, and metastasis [194, 195]. Here, PTK2 is linked to cancer.